These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Agonistic Hohberger B; Wörn M; Lämmer R; Mahajan A; Mardin C; Schötzer-Schrehardt U; Kunze R; Herrmann M; Wallukat G Front Immunol; 2021; 12():550236. PubMed ID: 34025634 [TBL] [Abstract][Full Text] [Related]
11. Changes in concentrations of tau-reactive antibodies are dependent on sex in Alzheimer's disease patients. Krestova M; Ricny J; Bartos A J Neuroimmunol; 2018 Sep; 322():1-8. PubMed ID: 29789140 [TBL] [Abstract][Full Text] [Related]
12. Production of autoantibodies to glutamate during Alzheimer's dementia. Davydova TV; Voskresenskaya NI; Gorbatov VY; Fomina VG; Doronina OA; Maksunova IV Bull Exp Biol Med; 2009 Apr; 147(4):405-7. PubMed ID: 19704934 [TBL] [Abstract][Full Text] [Related]
13. Antimicroglia antibodies in sera of Alzheimer's disease patients. Lemke MR; Glatzel M; Henneberg AE Biol Psychiatry; 1999 Feb; 45(4):508-11. PubMed ID: 10071725 [TBL] [Abstract][Full Text] [Related]
14. Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individuals. Katsel P; Tan W; Haroutunian V PLoS One; 2009 Oct; 4(10):e7642. PubMed ID: 19865478 [TBL] [Abstract][Full Text] [Related]
15. Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients. Hohberger B; Hosari S; Wallukat G; Kunze R; Krebs J; Müller M; Hennig T; Lämmer R; Horn F; Muñoz LE; Herrmann M; Mardin C PLoS One; 2021; 16(5):e0249202. PubMed ID: 33961631 [TBL] [Abstract][Full Text] [Related]
16. Functional autoantibodies in patients with different forms of dementia. Wallukat G; Prüss H; Müller J; Schimke I PLoS One; 2018; 13(3):e0192778. PubMed ID: 29538413 [TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to amyloid-beta and Alzheimer's disease. Hyman BT; Smith C; Buldyrev I; Whelan C; Brown H; Tang MX; Mayeux R Ann Neurol; 2001 Jun; 49(6):808-10. PubMed ID: 11409436 [TBL] [Abstract][Full Text] [Related]
18. Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma. Hohberger B; Kunze R; Wallukat G; Kara K; Mardin CY; Lämmer R; Schlötzer-Schrehardt U; Hosari S; Horn F; Munoz L; Herrmann M Front Immunol; 2019; 10():2112. PubMed ID: 31632387 [TBL] [Abstract][Full Text] [Related]
19. [Circulating human pituitary prolactin cell autoantibodies and Alzheimer's disease]. Pouplard A; Emile J; Vincent-Pineau F Rev Neurol (Paris); 1983; 139(3):187-91. PubMed ID: 6351215 [TBL] [Abstract][Full Text] [Related]